Glass House Brands Inc. GLAS
i
Market datapartial · fetched 2026-11-03T15:44:05.784Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-03T15:43:55.841931876Z
FundamentalsAlpha Vantage · unavailable
Glass House Brands Inc. options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 2.02 | 171.6% | 26.7% | |||
| 25Δ | 2.14 | 161.9% | 23.2% | |||
| 30Δ | 2.26 | 152.1% | 19.7% | |||
| 35Δ | 2.38 | 142.3% | 16.2% | |||
| 40Δ | 2.90 | 129.9% | 19.6% | 2.50 | 132.5% | 12.6% |
| 45Δ | 2.80 | 127.1% | 16.9% | 2.60 | 133.0% | 11.2% |
| 50Δ | 2.70 | 124.3% | 14.2% | 2.70 | 133.6% | 9.8% |
| 55Δ | 2.60 | 121.4% | 11.4% | 2.81 | 134.2% | 8.5% |
| 60Δ | 2.91 | 134.8% | 7.1% | |||
| 65Δ | ||||||
| 70Δ | 3.63 | 208.2% | 6.7% | |||
| 75Δ | ||||||
| 80Δ | ||||||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.02
- IV
- 171.6%
- B/E move
- 26.7%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.14
- IV
- 161.9%
- B/E move
- 23.2%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.26
- IV
- 152.1%
- B/E move
- 19.7%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.38
- IV
- 142.3%
- B/E move
- 16.2%
40Δ
- Pseudo strike
- 2.90
- IV
- 129.9%
- B/E move
- 19.6%
- Pseudo strike
- 2.50
- IV
- 132.5%
- B/E move
- 12.6%
45Δ
- Pseudo strike
- 2.80
- IV
- 127.1%
- B/E move
- 16.9%
- Pseudo strike
- 2.60
- IV
- 133.0%
- B/E move
- 11.2%
50Δ
- Pseudo strike
- 2.70
- IV
- 124.3%
- B/E move
- 14.2%
- Pseudo strike
- 2.70
- IV
- 133.6%
- B/E move
- 9.8%
55Δ
- Pseudo strike
- 2.60
- IV
- 121.4%
- B/E move
- 11.4%
- Pseudo strike
- 2.81
- IV
- 134.2%
- B/E move
- 8.5%
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.91
- IV
- 134.8%
- B/E move
- 7.1%
65Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.63
- IV
- 208.2%
- B/E move
- 6.7%
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 161.65% | |
| 111.32% | |
| 157.62% | |
| 164.11% | |
| 174.71% | |
| 193.47% | |
| 206.07% | |
| 144.86% | |
| 156.16% | |
| 163.83% |
Drug Manufacturers - Specialty & Generic
HCM
HUTCHMED (China) Limited discovers, develops and markets targeted immunotherapies and therapies for cancer and immune diseases globally. The company is headquartered in Central,…
More →HIMS
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers with licensed healthcare professionals. The company is headquartered in San…
More →HLN
Haleon plc (HLN) is a leading global consumer health company, emerging as a spin-off from GlaxoSmithKline, dedicated to providing innovative health solutions through a robust…
More →HROW
Harrow Health, Inc. is an ophthalmology-focused healthcare company. The company is headquartered in San Diego, California.
More →INCR
Syneos Health, Inc., a contract research organization, provides various clinical development services for the medical device and biopharmaceutical industries in North America,…
More →INDV
Description unavailable
More →